Learn about new treatment options, including the Hybrid Maze procedure, in a Free LiveCast Seminar from St. Helena Arrhythmia Center on November 18, 2014 6:30 – 8:00 PM PST. The Hybrid Maze is a new minimally invasive procedure for atrial fibrillation. Patients benefit from better outcomes, a shorter hospital stay, and quicker recovery. Dr. Gan …
Read More
Biosense Webster, Inc. and StopAfib.org have teamed up to raise awareness of atrial fibrillation and available treatment options through Get SMART About AfibSM, an interactive web experience. Learn more at: Biosense Webster Teams Up with StopAfib.org to Challenge Americans to Get SMART About AfibSM
Read More
Here's more good news about the upcoming antidote for Eliquis - see: Positive Results for Factor Xa Inhibitor Antidote: ANNEXA-A
Read More
MedQuery Inc, a national medical market research company that collaborates with pharmaceutical and medical device companies, is looking for people who have been diagnosed with Atrial Fibrillation to participate in a face to face interview research study in NEW YORK on October 7th and 8th. This study is aimed at improving AF treatment and understanding …
Read More
StopAfib.org has named four new atrial fibrillation experts — Dr. Kathleen T. Hickey, Dr. Dhanunjaya Lakkireddy, Dr. Jonathan M. Philpott, and Dr. Kathryn Wood — to its Global Medical Advisory Board. The Global Medical Advisory Board is made up of some of the world’s foremost electrophysiologists, surgeons, cardiologists, neurologists, epidemiologists, and researchers at the forefront …
Read More
Are you in the San Francisco area, or can you get there? Please join us for the Kickoff Conference of the Health eHeart Alliance Patient-Powered Research Network on November 6–7. We will identify research needs of the afib patient community and potential ways to address those needs. To learn more about the alliance and the …
Read More
Today, at the European Society of Cardiology Congress in Barcelona, it was reported that even though 80% of atrial fibrillation patients who should be on anticoagulants (according to their CHA2DS2-VASc score) are on anticoagulants, death rates at one year are still high. Most of those deaths are due to cardiovascular causes. The risk factors predicting …
Read More
Amazon Smile is the same Amazon you know already. Same products. Same prices. Same service. Now, by starting your shopping at smile.amazon.com, you can designate us to receive 0.5% of the price of your eligible purchases. You can support us without spending a cent more! It’s very easy to designate us as your supported charity …
Read More
New research from the University of California at San Francisco indicates that atrial flutter can be cured through catheter ablation and doing so can reduce the risk for atrial fibrillation. To learn more, see: Catheter Ablation a First-Line Treatment for Atrial Flutter
Read More
While attending several recent medical conferences, we learned about some interesting procedure clinical trials that may be of interest to the afib patient community. To learn more, check out the following studies: The nContact CONVERGE Trial Will Study the Convergent Procedure for Treatment of Persistent Atrial Fibrillation The reMARQable Trial Will Study the nMARQ Multielectrode …
Read More